Stapled Peptides That Block Protein Interactions Speed Up Wound Healing

Stapled peptides designed to inhibit VGLL4-TEAD4 protein interactions accelerate cutaneous wound healing by activating fibroblast-mediated tissue repair through the Hippo signaling pathway.

Chen, Shuai et al.·European journal of medicinal chemistry·2026·
RPEP-149942026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Stapled peptide inhibitors of VGLL4-TEAD4 interactions accelerated cutaneous wound healing by activating fibroblast proliferation through the Hippo pathway.

Key Numbers

How They Did This

Peptide design and synthesis with stapling modification; protein-protein interaction studies; wound healing assays in cell and tissue models.

Why This Research Matters

Chronic wounds affect millions of people, especially diabetics and the elderly. A peptide that directly activates the body's tissue repair machinery could provide a targeted wound healing therapeutic.

The Bigger Picture

This demonstrates how understanding fundamental cell growth pathways (Hippo/TEAD) can be translated into practical therapeutics using peptide engineering — a model for converting basic science into wound healing medicines.

What This Study Doesn't Tell Us

Preclinical study — human wound healing is more complex than models; peptide delivery to wound sites needs optimization; potential oncogenic concerns with growth pathway activation.

Questions This Raises

  • ?Could these stapled peptides be formulated into wound dressings for clinical use?
  • ?Does activating the Hippo pathway for wound healing carry any cancer risk?

Trust & Context

Key Stat:
Accelerated wound healing Stapled peptides activate Hippo pathway to boost fibroblast tissue repair
Evidence Grade:
Preclinical study with peptide design and wound model testing — proof of concept for a novel wound healing approach.
Study Age:
Published in 2026, applying stapled peptide technology to regenerative medicine.
Original Title:
Stapled peptide inhibitors target VGLL4/TEAD4 interactions to accelerate cutaneous wound healing.
Published In:
European journal of medicinal chemistry, 304, 118508 (2026)
Database ID:
RPEP-14994

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What are stapled peptides?

Stapled peptides have chemical "staples" (cross-links) that lock them into their active shape, making them more stable and effective than regular peptides. This overcomes a major limitation of peptide drugs — they normally degrade quickly.

How could this help with wound healing?

The peptides activate a growth pathway (Hippo/TEAD) in skin repair cells (fibroblasts), telling them to multiply and rebuild tissue. This could be applied topically to chronic wounds that won't heal on their own.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-14994·https://rethinkpeptides.com/research/RPEP-14994

APA

Chen, Shuai; Gai, Conghao; Wang, Guangyao; Dong, Peng; Zhuo, Xiaobin; Zhang, Wenwen; Zhang, Pei-Chao; Chai, Xiaoyun; Xue, Hongjuan; Su, Juan; Zhao, Qingjie; Zou, Yan. (2026). Stapled peptide inhibitors target VGLL4/TEAD4 interactions to accelerate cutaneous wound healing.. European journal of medicinal chemistry, 304, 118508. https://doi.org/10.1016/j.ejmech.2025.118508

MLA

Chen, Shuai, et al. "Stapled peptide inhibitors target VGLL4/TEAD4 interactions to accelerate cutaneous wound healing.." European journal of medicinal chemistry, 2026. https://doi.org/10.1016/j.ejmech.2025.118508

RethinkPeptides

RethinkPeptides Research Database. "Stapled peptide inhibitors target VGLL4/TEAD4 interactions t..." RPEP-14994. Retrieved from https://rethinkpeptides.com/research/chen-2026-stapled-peptide-inhibitors-target

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.